EE200300567A - Meetod amorfse naatrium-tsilastatiini valmistamiseks - Google Patents

Meetod amorfse naatrium-tsilastatiini valmistamiseks

Info

Publication number
EE200300567A
EE200300567A EEP200300567A EEP200300567A EE200300567A EE 200300567 A EE200300567 A EE 200300567A EE P200300567 A EEP200300567 A EE P200300567A EE P200300567 A EEP200300567 A EE P200300567A EE 200300567 A EE200300567 A EE 200300567A
Authority
EE
Estonia
Prior art keywords
preparation
cilastatin sodium
amorphous
amorphous cilastatin
sodium
Prior art date
Application number
EEP200300567A
Other languages
English (en)
Estonian (et)
Inventor
Kumar Yatendra
Dutt Tyagi Om
Rohtagi Amit
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of EE200300567A publication Critical patent/EE200300567A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/04Methanol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
EEP200300567A 2001-05-18 2002-05-17 Meetod amorfse naatrium-tsilastatiini valmistamiseks EE200300567A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN593DE2001 2001-05-18
PCT/IB2002/001696 WO2002094742A1 (en) 2001-05-18 2002-05-17 Process for the preparation of amorphous cilastatin sodium

Publications (1)

Publication Number Publication Date
EE200300567A true EE200300567A (et) 2004-04-15

Family

ID=11097060

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300567A EE200300567A (et) 2001-05-18 2002-05-17 Meetod amorfse naatrium-tsilastatiini valmistamiseks

Country Status (24)

Country Link
US (1) US20040152780A1 (no)
EP (1) EP1395530A4 (no)
JP (1) JP2004526805A (no)
KR (1) KR20040044409A (no)
CN (1) CN1522235A (no)
AP (2) AP1511A (no)
AR (1) AR036017A1 (no)
BG (1) BG108447A (no)
BR (1) BR0209843A (no)
CA (1) CA2447788A1 (no)
CZ (1) CZ20033352A3 (no)
EA (1) EA005947B1 (no)
EE (1) EE200300567A (no)
HR (1) HRP20031052A2 (no)
HU (1) HUP0400825A2 (no)
IL (1) IL158945A0 (no)
MX (1) MXPA03010547A (no)
NO (1) NO20035138D0 (no)
NZ (1) NZ529625A (no)
OA (1) OA12607A (no)
PL (1) PL367937A1 (no)
SK (1) SK15082003A3 (no)
WO (1) WO2002094742A1 (no)
ZA (1) ZA200309287B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402312B1 (en) 2005-11-09 2013-07-17 Orchid Chemicals&Pharmaceuticals Limited An improved process for the preparation of cilastatin acid
WO2011080648A1 (en) * 2010-01-01 2011-07-07 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of cilastatin sodium
CN102675175B (zh) * 2011-03-08 2014-02-19 深圳市海滨制药有限公司 一种西司他丁的分离纯化方法
US11324804B2 (en) 2016-11-18 2022-05-10 Sepsia Therapeutics, S.L. Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
EP0441371B1 (en) * 1990-02-08 1995-01-25 Sumitomo Chemical Company, Limited Process for preparing haloketo acid derivatives
US5166417A (en) * 1990-09-04 1992-11-24 Lonza Ltd. Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
CA2056840A1 (en) * 1990-12-17 1992-06-18 Thomas Meul Process for the production of dimethylcyclopropanecarboxylic acid
DE59209523D1 (de) * 1991-07-26 1998-11-19 Lonza Ag Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (no) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EA005947B1 (ru) 2005-08-25
MXPA03010547A (es) 2004-05-27
CN1522235A (zh) 2004-08-18
EA200301225A1 (ru) 2004-06-24
AR036017A1 (es) 2004-08-04
PL367937A1 (en) 2005-03-07
EP1395530A1 (en) 2004-03-10
US20040152780A1 (en) 2004-08-05
SK15082003A3 (sk) 2004-06-08
NO20035138D0 (no) 2003-11-18
CA2447788A1 (en) 2002-11-28
BG108447A (en) 2005-03-31
AP2003002913A0 (en) 2003-12-31
OA12607A (en) 2006-06-08
CZ20033352A3 (en) 2004-06-16
HUP0400825A2 (hu) 2004-08-30
IL158945A0 (en) 2004-05-12
EP1395530A4 (en) 2006-01-18
BR0209843A (pt) 2004-08-24
HRP20031052A2 (en) 2004-06-30
KR20040044409A (ko) 2004-05-28
AP2003002912A0 (en) 2002-05-17
JP2004526805A (ja) 2004-09-02
ZA200309287B (en) 2004-07-22
NZ529625A (en) 2006-02-24
WO2002094742A1 (en) 2002-11-28
AP1511A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
IS2940B (is) Mótefni gegn CD40
EP1425279A4 (en) PROCESS FOR THE PREPARATION OF CRYSTALLINE TETRAHYDROBENZOTHIEPINES
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
SI1423360T1 (sl) Postopek za izdelavo cilastatina
EE05403B1 (et) Tehniline snteesimeetod tropenooli valmistamiseks
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
EE200300567A (et) Meetod amorfse naatrium-tsilastatiini valmistamiseks
ITMI20021031A0 (it) Procedimento per preparare policarbonato-polioli
DE60226093D1 (de) Urmedium-Reinigungsmethode
PT1401845E (pt) Processo para a preparacao de n-fosfonometilglicina
FI20012552A (fi) Metallikarbonaatin valmistusmenetelmä
ITMI20000261A0 (it) Processo per la preparazione di piridiniliden-ftalidi
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
FR2829759B1 (fr) Procede de preparation de polyhydroxystilbenes symetriques
NO20022643D0 (no) Reduksjonsprosess
ITMI20012131A0 (it) Procedimento per la preparazione di alo-benzonitrili
FI20000535A0 (fi) Menetelmä kuparin valmistamiseksi
ITMI20020620A1 (it) Procedimento per la preparazione di alchil-benzoati per esterificazione di benzoil-fluoruri
FR2829492B1 (fr) Procede de preparation de la disorbitylamine
PL348215A1 (en) Method of obtaining 1-amino-2-hydroxyalkane salts
NO20015625D0 (no) Fremgangsmåte for reduksjon av NOx
PT102405A (pt) Processo para a preparacao de mometasona